How much does orbactiv cost?

Orbactiv (generic name: gemigliptin) is a prescription medication used to treat severe hypertriglyceridemia. Its price can vary quite a bit depending on where you live, your insurance coverage, and any manufacturer or pharmacy benefit manager (PBM) agreements that might apply.

| Factor | Typical Cost |
|--------|--------------|
| United States (list price) | Roughly $3,000–$4,000 per month for the 30‑tablet pack (≈ $100–$130 per tablet). |
| With insurance | Copay or coinsurance can drop the out‑of‑pocket amount to a few hundred dollars per month, but it depends on your plan’s formulary tier, deductible, and copayment structure. |
| Generic (if available in your country) | Usually lower, but gemigliptin has not yet been widely marketed generically in many markets. |
| Patient assistance programs | Orbactiv offers a co‑pay card that can reduce the copay for qualified patients by up to $300–$400 per month. |

How to find your exact cost

1. Check your insurance formulary – look for Orbactiv or its generic name.
   
2. Call the pharmacy – they can pull the most current copay based on your insurance.
   
3. Ask your prescriber – they often have access to discount cards or manufacturer assistance programs.
   
4. Visit the manufacturer’s website – they list the co‑pay card options and eligibility criteria.
   
   If you’re in a country outside the U.S., the list price is usually lower (e.g., €80–€120 per 30‑tablet pack in some European markets), but insurance or national health system coverage will still drive the out‑of‑pocket cost.
   
   ---
   
   Quick tip: Because the price of Orbactiv is so high, many prescribers and patients consider alternative triglyceride‑lowering therapies (e.g., omega‑3 fatty acids, niacin, or fibrates) and lifestyle modifications first, reserving Orbactiv for truly severe cases that haven’t responded to other measures.
   
   Let me know if you’d like help estimating your specific copay or finding a discount program!